Skip to main content

Find Clinical Trials

Home
Conditions
Herpesviridae Infections

Clinical trial condition

Herpesviridae Infections

Explore clinical trials studying Herpesviridae Infections. Study availability and eligibility vary by location and protocol.

1,824 public trials 252 recruiting studies

Refine in advanced search Browse all conditions

Herpesviridae Infections trial results

Completed

Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)

NCT02062502

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)

NCT02519855

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Not specified

View Trial Details

Completed

Zoster Vaccine Response in the Frail Elderly

NCT01328548

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations: Macassa Lodge Hamilton, Ontario, Canada

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00005092

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +77 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Washington University Barnard Cancer Center St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

NCT01777321

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: GSK Investigational Site Fukuoka, Japan

View Trial Details

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

NCT01827839

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: GSK Investigational Site Coquitlam, British Columbia, Canada

GSK Investigational Site Pointe-Claire, Quebec, Canada

GSK Investigational Site Barnaul, Russia

GSK Investigational Site Yekaterinburg, Russia

View Trial Details

Completed

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

NCT01751165

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: GSK Investigational Site Spring Valley, California, United States

GSK Investigational Site Wichita, Kansas, United States

GSK Investigational Site Uniontown, Pennsylvania, United States

GSK Investigational Site Tartu, Estonia

View Trial Details

Completed

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

NCT00194519

Conditions: Behavior, Blood-Borne Infections, Coitus, +28 more
Locations: Botswana-Harvard Partnership Gabarone, Botswana

Moi University - Indiana University Eldoret, Kenya

Kemri - Ucsf Kisumu, Kenya

University of Nairobi Nairobi, Kenya

View all 13 locations

View Trial Details

Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

NCT00578175

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Tuscaloosa, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 141 locations

View Trial Details

Completed

Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection

NCT01509404

Conditions: Cytomegalovirus Disease, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations: Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details